Get the Stockscreener App
0.6083
2.30%
0.0137
Pre-market:
.61
0.0017
+0.28%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.6083, with a volume of 3.12M.
It is up +2.30% in the last 24 hours and up +10.00% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.5946
Open:
$0.6
24h Volume:
3.12M
Relative Volume:
0.33
Market Cap:
$69.99M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.9358
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
+16.42%
1M Performance:
+10.00%
6M Performance:
-25.32%
1Y Performance:
-51.34%
1-Day Range:
$0.5958
$0.62
1-Week Range:
$0.5289
$0.63
52-Week Range:
$0.2522
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.6083 | 68.41M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
How supply chain issues affect Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Reviva’s Schizophrenia Bet Pits Huge Upside Against Harsh Risks - Finimize
Is I G Petrochemicals Limiteds Valuation Cheap Compared to Growth PeersVolatility Trading Techniques & Low Risk Trading Plans - earlytimes.in
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock maintain growth trajectory2025 Trading Recap & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
Largest borrow rate increases among liquid names - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
EBIT per share of Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva Pharm – NASDAQ:RVPHW - TradingView
RVPH: Brilaroxazine Poster Presentations - Yahoo Finance
Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva Pharm - TradingView
How currency fluctuations impact Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockLayoff News & Real-Time Volume Analysis Alerts - newser.com
Reviva Pharmaceuticals Holdings (RVPH) Price Target Increased by 34.17% to 5.86 - MSN
Is Reviva Pharmaceuticals Holdings Inc. forming a bottoming baseChart Signals & Stepwise Swing Trade Plans - newser.com
Why Reviva Pharmaceuticals Holdings Inc. stock is popular among millennialsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs after earnings2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Full technical analysis of Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockTrade Entry Report & Weekly Momentum Picks - newser.com
Free cash flow per share of Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva - TradingView
Order flow analysis tools used on Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock dividend yield sustainableMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
MSN Money - MSN
Best data tools to analyze Reviva Pharmaceuticals Holdings Inc. stock2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformationQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. Equity Warrant explainedLayoff News & Weekly Top Stock Performers List - newser.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Key resistance and support levels for Reviva Pharmaceuticals Holdings Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Reviva Pharmaceuticals Holdings options imply 21.1% move in share price post-earnings - MSN
What indicators show strength in Reviva Pharmaceuticals Holdings Inc. Equity WarrantMarket Movement Recap & AI Driven Price Forecasts - newser.com
Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options data2025 Performance Recap & Technical Entry and Exit Alerts - newser.com
Reviva Pharmaceuticals reports Q3 EPS (6c), consensus (10c) - MSN
Price action breakdown for Reviva Pharmaceuticals Holdings Inc. Equity Warrant - newser.com
Risk adjusted return profile for Reviva Pharmaceuticals Holdings Inc. Equity Warrant analyzedGlobal Markets & Community Trade Idea Sharing Platform - newser.com
What analysts say about Reviva Pharmaceuticals Holdings Inc stockEarnings Beat Highlights & Interactive Charts for Smarter Trading - earlytimes.in
Reviva Cuts Losses And Draws Optimism On New Drug Hopes - Finimize
Reviva Pharmaceuticals Win Analyst Praise Despite Losses Narrowing - Finimize
Is Reviva Pharmaceuticals Holdings Inc. building a consolidation base2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):